Table III.
O2 (%) | 2-ME | CPA | CPA+2-ME | R index | Effect |
---|---|---|---|---|---|
16.2 | 94.35±7.3 | 56.8±1.7a | 54.2±3.3 | 0.99±0.06 | No effect |
1 | 95.6±7.0 | 54.3±1.9a | 27.3±2.1b | 1.92±0.13c | Additivity |
0.1 | 93.2±3.0 | 55.5±1.5a | 30.2±2.1b | 1.74±0.11c | Additivity |
2-ME | IFA | IFA+2-ME | R index | Effect | |
16.2 | 93.9±1.0 | 53.7±2.2a | 48.6±2.0 | 1.04±0.02 | No effect |
1 | 94.4±1.2 | 49.7±2.5a | 23.6±2.3b | 2.03±0.12c | Synergy |
0.1 | 95.4±1.6 | 48.8±2.9a | 26.5±1.9b | 1.77±0.10c | Additivity |
Cells were incubated for 24 h under normoxia (16.2% O2) or hypoxia (1 or 0.1% O2) with CPA or IFA in the absence and the presence of 2-ME (5 µM) and cell viability was determined with the MTT assay. Values are expressed as the percentage of the control cell viability (no drugs added) and are means ± SEM from five independent experiments.
P<0.001 vs. 2-ME
P<0.01 vs. CPA or IFA alone
P<0.01 vs. the R index of cells incubated under normoxia; one-way ANOVA and Tukey's test. The R index was calculated as described in Materials and methods. 2-ME, 2-methoxyestradiol; CPA, cyclophosphamide; IFA, ifosfamide.